Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$RNAC

Cartesian Therapeutics, Inc. Common Stock

XNASHealth CarePharmaceutical Preparations

$10.04
-1.86%-$0.190
RVOL peak today
Normal
Halted today
None today
Float
9.9M
Next earnings
Unscheduled
$10.04-1.86%$0.1900Prev $10.23LIVE Full chart Live alerts
No recent price bars, the chart lights up when RNAC starts printing.

Why is RNAC down today? It is at $10.04 (-1.86%), and our scanner flagged it 8 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RNAC spikes, and full due diligence on RNAC — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $RNAC alerts the moment volume spikes

Our scanner flagged $RNAC 8 times in the last 30 days. Create a free account to track $RNAC, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$10.04
Change today
-1.86%
Previous close
$10.23
52-week range
$5.60 – $11.38
Valuation & dividend
Market cap
$304M
Ownership & volume
Shares outstanding
30.3M
SEC · as of 2026-07-31 · 23d
Insider ownership
36.8%
DEF 14A · 2026-04-28
Institutional own.
30.62%
Total held
67.4%
Tradeable float
9.9M
33% of shares · after 37% insiders + 31% institutions
Short interest
1.8M
▼ -4% vs prior · as of 2026-07-31
Short % of float
18.7%
Days to cover
14.9d
Avg daily volume
187K
Classification
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
XNAS
Relative volumevs this time of day
5m
0.8x
15m
0.6x
1hthin
0.5x
1D
--

Get free RNAC + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $RNAC down today?

Here is the latest on RNAC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RNAC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

Latest filingSC 13GPassive 5%+ stake disclosedAug 13, 2026 · 9 days ago
Why is $RNAC moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profileLow float · 9.9M shShortableEasy to borrowNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusStrong Buy8 analysts
Avg target $33.83(+237% upside)
Range $16 - $44
8 buy0 hold0 sell

Analyst data via Nasdaq. Not investment advice.

Insiders

0 buys, 0 sells last 3 months (14/5 over 12 months)
Show 12 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Kalayoglu Murat
Beneficial Owner (10%)
Other758K
2.5% of company
added 17%5.31Mn/aApr 2, 26
Hoge Elizabeth
Beneficial Owner (10%)
Other758K
2.5% of company
added 15%5.82Mn/aApr 2, 26
Singer Michael
Director
Sold (automatic/other)-7K
0.02% of company
sold 12%50Kn/aMar 13, 26
Davis Blaine
Officer
Sold (automatic/other)-11K
0.04% of company
sold 8.0%121K$72K
at $6.82
Jan 6, 26
Miljkovic Milos
Officer
Sold (automatic/other)-4K
0.01% of company
sold 5.7%59K$24K
at $6.82
Jan 6, 26
Brunn Carsten
Officer
Sold (automatic/other)-24K
0.08% of company
sold 6.8%324K$162K
at $6.82
Jan 6, 26
Kalayoglu Murat
Director
Acquired (grant/award)+3Kadded 0.5%512Kn/aJan 2, 26
Springer Timothy A
Director
Acquired (grant/award)+3Kadded <0.1%8.65Mn/aJan 2, 26
Singer Michael
Director
Acquired (grant/award)+3Kadded 4.9%56Kn/aJan 2, 26
English Emily
Officer
Acquired (grant/award)+24K
0.08% of company
added 34%94Kn/aJan 2, 26
Barabe Timothy C
Director
Acquired (grant/award)+3Kadded 4.8%57Kn/aJan 2, 26
Davis Blaine
Officer
Acquired (grant/award)+37K
0.1% of company
added 39%132Kn/aJan 2, 26

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

$RNAC Sentiment

Bullish
Bearish73Bullish
📰 News: 4 bull · 0 bearToday: -1.9%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$RNAC Activity

News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.

Alert· 3d ago +9.3% vs EMA
RNAC 200EMA (5m) Trending · 68 bars · L3 · +9.33% above EMA · slope +2.12%
at $10.51
Alert· 3d ago +4.4% vs EMA
RNAC 200EMA (1m) Trending · 159 bars · L4 · +4.39% above EMA · slope +1.40%
at $10.51
Alert· 3d ago +2.0% vs EMA
RNAC 50EMA (5m) Trending · 68 bars · L3 · +1.97% above EMA · slope +2.94%
at $10.51
Alert· 4d ago +2.47%
$RNAC moved +2.47% in 1 min (Level 1) at 2:50 PM ET
at $10.63
Alert· 4d ago 7.7× RVOL
RNAC hit 7.686x RVOL at 2:50 PM ET
at $10.61
Alert· 4d ago +2.49%
$RNAC moved +2.49% in 1 min (Level 2) at 2:07 PM ET
at $10.27
Alert· 4d ago 19.2× RVOL
RNAC hit 19.231x RVOL at 2:07 PM ET
at $10.27
Alert· 4d ago 10.1× RVOL
RNAC hit 10.049x RVOL at 12:21 PM ET
at $10.14
Alert· 4d ago 19.1× RVOL
RNAC hit 19.051x RVOL at 11:54 AM ET
at $10.07
News· SEC EDGAR· 17d ago
Cartesian Therapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026
News· SEC EDGAR· 17d ago
Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Alert· 18d ago +1.4% vs EMA
RNAC 200EMA (5m) Trending · 66 bars · L3 · +1.38% above EMA · slope +0.65%
at $8.07
Alert· 19d ago 2.4× RVOL
RNAC hit 2.409x RVOL at 11:23 AM ET
at $8.37
Alert· 29d ago 8.1× RVOL
RNAC hit 8.059x RVOL at 3:16 PM ET
at $7.82
Alert· 32d ago -1.00%
$RNAC moved -1.00% in 1 min (Level 1) at 9:54 AM ET
at $8.06
News· SEC EDGAR· 66d ago
Cartesian Therapeutics, Inc. filed an 8-K: Shareholder Vote
News· SEC EDGAR· 75d ago
Cartesian Therapeutics, Inc. filed an 8-K: Regulation FD Disclosure
News· GlobeNewswire Inc.· 82d ago Bullish
Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight
News· GlobeNewswire Inc.· 89d ago Bullish
Cartesian Therapeutics Secures up to $150 Million of Non-Dilutive Financing from K2 HealthVentures and Expects Topline Data from the Phase 3 AURORA Trial in First Quarter 2027
News· GlobeNewswire Inc.· 97d ago Bullish
Myasthenia Gravis Market Set to Surpass USD 16 Billion by 2036, Fueled by Rising Diagnosed Prevalence and Wave of Targeted Biologic Approvals | DelveInsight
News· GlobeNewswire Inc.· 103d ago Bullish
Cartesian Therapeutics to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

Related PHARMACEUTICAL stocks

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

RNAC stock FAQ

Why is $RNAC down today?

Here is the latest on RNAC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RNAC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

What is the RNAC stock price today?

RNAC last traded at $10.04, down 1.86% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live RNAC alerts?

The RNAC Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RNAC 8 times in the last 30 days.

What exchange is RNAC on?

RNAC (Cartesian Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $304M in the PHARMACEUTICAL PREPARATIONS sector.

Is RNAC good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RNAC for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.